Paris, France and Camberley, UK – 26 April 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with the Department of Health and Social Care (“DHSC”).
http://novacyt.com/wp-content/uploads/2022/04/Novacyt-DHSC-dispute-update-1.pdf